HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

trioxifene

RN given refers to parent cpd
Also Known As:
3,4-dihydro-2-(p-methoxyphenyl)-1-naphthyl p-(2-(1-pyrrolidinyl)ethoxy)phenylketone; LY 133314; LY 88571; Lilly 133314; Lilly 88571; trioxifene mesylate; trioxifene methanesulfonate; Methanone, (3,4-dihydro-2-(4-methoxyphenyl)-1naphthalenyl)(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-
Networked: 7 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Osborne, Harold E: 1 article (09/2003)
2. Graff, Jeremy R: 1 article (09/2003)
3. Goode, Robin L: 1 article (09/2003)
4. Chen, Keyue: 1 article (09/2003)
5. Lynch, Rebecca: 1 article (09/2003)
6. Krishnan, Venkatesh: 1 article (09/2003)
7. Neubauer, Blake Lee: 1 article (09/2003)
8. Johnson, Mac A: 1 article (09/2003)
9. McNulty, Ann M: 1 article (09/2003)
10. Jones, C David: 1 article (09/2003)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Carcinoma (Carcinomatosis)
3. Neoplasms (Cancer)
4. Neoplasm Metastasis (Metastasis)

Related Drugs and Biologics

1. Estrogen Receptor Modulators (Antiestrogen)
2. Tamoxifen
3. Toremifene (Fareston)
4. 3-hydroxytamoxifen (droloxifene)
5. LY 117018
6. Raloxifene (Evista)
7. Selective Estrogen Receptor Modulators (SERM)
8. Methylnitrosourea (N-Methyl-N-nitrosourea)
9. Eflornithine (Ornidyl)
10. hydroxytamoxifen